PRTN3 and rheumatoid arthritis: Interestingly, aside from the lower levels of composite measures of RA disease activity, RF−/ACPA+ patients had significantly lower levels across most of the individual clinical and laboratory disease activity variables and physical function compared not only with double-positive patients but also with those who were RF+/ACPA−.